home All News open_in_new Full Article

United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin

United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin  Yahoo Finance


today 5 h. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Science
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 1600302590
Add Watch Country

arrow_drop_down